Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment-Reference-Cited by-同舟云学术

Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment

Published:2020-06-22 Issue:3 Volume:72 Page:668-691
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Wijaya Juwina,Gose Tomoka,Schuetz John D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference179 articles.

1. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response;Abaji;Pharm Genomics Pers Med,2017

2. High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X;Abromowitch;Med Pediatr Oncol,1988

3. Medu-33. human cerebellar organoids as a new 3d model of medulloblastoma;Anderle;Neuro Oncol,2019

4. Establishment of a human blood-brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells;Appelt-Menzel;Stem Cell Reports,2017

5. Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian Modelling of Response to Therapy and Drug-Sensitivity in Acute Lymphoblastic Leukemia;Statistics in Biosciences;2024-05-29

2. Cancer: slaying the nine-headed Hydra;Annals of Oncology;2023-01

3. Small Molecules as Promising Tool for Targeted Cancer Therapies: An Overview of the Twenty-First Century;Drugs and a Methodological Compendium;2023

4. A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia;BioMed Research International;2022-08-21

5. Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia;Current Medical Science;2022-07-21